Cardiac Dimensions, a Kirkland, Wash., company with a technology to treat heart valve malfunction, has raised $53 million from investors.… Read More Cardiac Dimensions, a medical device company based ...
KIRKLAND, WA-- Cardiac Dimensions®, Inc. today announced that an update to its landmark TITAN clinical trial will be given as part of the 23rd annual Transcathether Cardiovascular Therapeutics (TCT) ...
KIRKLAND, Wash. -- Cardiac Dimensions®, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure, today ...
Cardiac Dimensions, a medical device company based in Kirkland, Wash., landed $35 million to support testing and marketing of its system to treat mitral valve regurgitation. Mitral valve regurgitation ...
KIRKLAND, Wash.--(BUSINESS WIRE)--Cardiac Dimensions®, a leader in transcatheter therapies for heart failure, announced today the appointment of William T. Abraham, MD, as Chief Medical Officer. A ...
Funds Expected to Support Enrollment in U.S. Pivotal EMPOWER Trial and European Commercial Expansion for Carillon Mitral Contour System® KIRKLAND, Wash.--(BUSINESS WIRE)--Cardiac Dimensions®, a leader ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Kirkland-based company is ...
Cardiac Dimensions, a Kirkland medical device company, has secured $12 million in venture capital financing from Polaris Venture Partners, InterWest Venture Partners and MPM Capital. The company, ...
Cardiac Dimensions has secured $53m in a Series E funding round to support its ongoing pivotal trial assessing the company’s mitral valve repair device. The round was led by investment management firm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results